← Every applicant
Steriscience FDA Approvals
10 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NAFCILLIN SODIUMNew drugSep 25, 2026INJECTABLE, INJECTION |
| SUGAMMADEX SODIUMNew drugJul 28, 2026SOLUTION, INTRAVENOUS |
| DOXYCYCLINE HYCLATENew drugNov 6, 2025INJECTABLE, INJECTION |
| VANCOMYCIN HYDROCHLORIDENew drugOct 2, 2025POWDER, INTRAVENOUS |
| ZIPRASIDONE MESYLATENew drugSep 3, 2025POWDER, INTRAMUSCULAR |
| METHYLENE BLUENew drugNov 22, 2024SOLUTION, INTRAVENOUS |
| ROCURONIUM BROMIDENew drugJul 22, 2024INJECTABLE, INJECTION |
| SUCCINYLCHOLINE CHLORIDENew drugJul 9, 2024SOLUTION, INTRAMUSCULAR, INTRAVENOUS |
| FOCINVEZNew drugAug 22, 2023SOLUTION, INTRAVENOUS |
| SODIUM BICARBONATENew drugJun 28, 2023SOLUTION, INTRAVENOUS |